Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study

E-ISSN： 1097-0215|142|7|1332-1342

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.142, Iss.7, 2018-04, pp. : 1332-1342

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: The EPIC study

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 5, 2015-03 ,pp. : 1218-1227

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cytologic diagnostic approach to poorly differentiated thyroid carcinoma: A single‐institution study

CANCER CYTOPATHOLOGY, Vol. 123, Iss. 2, 2015-02 ,pp. : 82-91

John Wiley & Sons Inc

Access to resources Recommend Favorite

Scoring Patients’ Risk in Differentiated Thyroid Cancer

Oncology Research and Treatment, Vol. 24, Iss. 6, 2002-01 ,pp. : 561-568

Karger

Access to resources Recommend Favorite

Multinucleated Giant Cells' Incidence, Immune Markers, and Significance: A Study of 172 Cases of Papillary Thyroid Carcinoma

By Brooks Erin

Head and Neck Pathology, Vol. 3, Iss. 2, 2009-06 ,pp. : 95-99

Humana Press, Inc

Access to resources Recommend Favorite

The limit of detection in scintigraphic imaging with I-131 in patients with differentiated thyroid carcinoma

By Hänscheid H Lassmann M Buck A K Reiners C Verburg F A

Physics in Medicine and Biology, Vol. 59, Iss. 10, 2014-05 ,pp. : 2353-2368

IOP Publishing

Access to resources Recommend Favorite